Vildagliptin/Metformin Krka

Vildagliptin/Metformin Krka combines two antidiabetic medications to support blood sugar management. This oral treatment is prescribed for type 2 diabetes alongside diet and exercise. It helps regulate glucose levels by targeting multiple pathways. Suitable for adults with insufficient control from metformin alone.

Vildagliptin/Metformin Krka is used to improve blood sugar control in adults with type 2 diabetes. It combines vildagliptin, a DPP-4 inhibitor, with metformin, a biguanide, to enhance insulin production and reduce glucose production. This combination therapy is often prescribed when diet and exercise alone are insufficient. It may also be used alongside other diabetes medications as directed by a healthcare provider.

This medication helps maintain steady blood sugar levels throughout the day. Users may experience more consistent energy levels and reduced symptoms of high blood sugar. Some report improved overall well-being as glucose control stabilizes. Individual responses vary based on diet, activity, and other factors.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Do not use if the packaging is damaged or shows signs of tampering. Inform your healthcare provider about all medications and supplements you take before starting this treatment. Regular blood sugar monitoring is recommended.

Alcohol may increase the risk of lactic acidosis when combined with metformin. Certain medications, such as diuretics or corticosteroids, may affect blood sugar levels. CYP inhibitors or inducers can alter vildagliptin levels in the body. Always consult a healthcare professional before combining with other drugs.